Our Helplines
Pregnancy & Breastfeeding Resources
- Morning Sickness
- Drugs in Pregnancy
- Alcohol, Nicotine, Substance Use
- Folic Acid
- Breastfeeding & Drugs
- Cancer in Pregnancy [Forum]
- HIV and HIV Treatment
- Conditions in Pregnancy
- Infectious Diseases in Pregnancy
- Nutrition
- Occupational & Environmental Exposures
- Pharmacokinetics/ Drug Metabolism
- PregTox
- The ReproPsych Group
- CAS Newsletter
Be sure to join us for the 11th Annual Fetal Alcohol Canadian Expertise (FACE) Research Roundtable. Program and registration details.
-
Aug252010
-
Jan112010
-
Dec222009
-
Nov92009
- Read more in our News Archive
Current Studies at Motherisk
-
Oxycodone while Breastfeeding
-
Alcohol Use during Pregnancy
-
Control of Hypertension in Pregnancy Study
-
Folic Acid Before and During Pregnancy
-
Lamisil in Pregnancy
-
Meridia in Pregnancy
-
Nicotine Replacement Therapy During Pregnancy
-
Rheumatoid Arthritis & Arava in Pregnancy
-
Severe Morning Sickness
Anti-convulsants: Carbamazepine
Further Reading
-
JAMA 271: 767-770, 1994.
Scolnik D, Nulman I, Rovet J, Gladstone D, Czuchta D, Gardner A, Gladstone R, Ashby P, Weksberg R, Einarson T, Koren G: Neurodevelopment of children exposed in utero to carbamazepine monotherapy. -
Am J Hum Genet 68: 18-24, 1997.
Nulman I, Scolnik D, Chitayat D, Farkas LD, Koren G: Dysmorphology in children exposed in utero to phenytoin and carbamazepine monotherapy; Independent effects of epilepsy and medications. -
Koren G: In utero exposure to phenytoin or carbamazepine. Can Fam Physicians 41: 1862-1863, 1995. -
Koren G: Neurodevelopment after in utero exposure to phenytoin and carbamazepine. JAMA 272: 850-851, 1994.













![Validate my RSS feed [Valid RSS]](/images/rssValid.png)